Neo-Adjuvant Chemo/Immunotherapy in the Treatment of Stage III (N2) Non-Small Cell Lung Cancer: A Phase I/Ii Pilot Study

International Journal of Immunopathology and Pharmacology - Italy
doi 10.1177/039463201102400418

Related search